[go: up one dir, main page]

CN118903670A - Special-shaped channel double-structure microneedle device for repairing soft tissue defects - Google Patents

Special-shaped channel double-structure microneedle device for repairing soft tissue defects Download PDF

Info

Publication number
CN118903670A
CN118903670A CN202410953806.6A CN202410953806A CN118903670A CN 118903670 A CN118903670 A CN 118903670A CN 202410953806 A CN202410953806 A CN 202410953806A CN 118903670 A CN118903670 A CN 118903670A
Authority
CN
China
Prior art keywords
microneedle
special
layer
shaped channel
shaped
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202410953806.6A
Other languages
Chinese (zh)
Inventor
庄俭
康晓雅
朱敬先
胡晓青
韩庆欣
高强
张笑宁
李明
孙靖尧
黄尧
许红
高小龙
吴大鸣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing University of Chemical Technology
Peking University Third Hospital Peking University Third Clinical Medical College
Original Assignee
Beijing University of Chemical Technology
Peking University Third Hospital Peking University Third Clinical Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing University of Chemical Technology, Peking University Third Hospital Peking University Third Clinical Medical College filed Critical Beijing University of Chemical Technology
Priority to CN202410953806.6A priority Critical patent/CN118903670A/en
Publication of CN118903670A publication Critical patent/CN118903670A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023Drug applicators using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046Solid microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明公开了一种软组织缺损修复的异形通道双结构微针装置,包括:可注射细胞外基质材料、树状异形通道微针基底矩阵、圆锥型直通道微针基地矩阵、微针隔离片。基底矩阵的针尖上有四层物质覆盖,从内到外分别为止血抗菌层、保护层、止血离子层和生物营养层;基底矩阵背面覆有医疗级别隔离片。异性微针基底矩阵片分为两种:第一类分层异形通道长微针、底端圆形托槽、上层树状分层针体,内部贯有树状异性通道;第二类单层短微针,针体呈锥形,内部贯有圆柱形直通道。本发明可有效穿透关节软组织利用不同角度的异形通道微针矩阵贴合人体关节部位,能最大程度上减轻微针的质量,加大治疗药液的输送率,快速修复组织缺损的目标。

The present invention discloses a special-shaped channel double-structure microneedle device for repairing soft tissue defects, comprising: an injectable extracellular matrix material, a tree-shaped special-shaped channel microneedle base matrix, a conical straight channel microneedle base matrix, and a microneedle isolation sheet. The needle tip of the base matrix is covered with four layers of material, which are a hemostatic antibacterial layer, a protective layer, a hemostatic ion layer, and a biological nutrition layer from the inside to the outside; the back of the base matrix is covered with a medical-grade isolation sheet. The heterogeneous microneedle base matrix sheets are divided into two types: the first type has long layered special-shaped channel microneedles, a circular bracket at the bottom, and an upper layer of tree-shaped layered needle bodies, and a tree-shaped heterogeneous channel is penetrated inside; the second type has a single-layer short microneedle, a cone-shaped needle body, and a cylindrical straight channel is penetrated inside. The present invention can effectively penetrate the soft tissue of the joint and use the special-shaped channel microneedle matrix at different angles to fit the joint parts of the human body, which can reduce the mass of the microneedle to the greatest extent, increase the delivery rate of the therapeutic liquid, and quickly repair the goal of tissue defects.

Description

一种软组织缺损修复的异形通道双结构微针装置A special-shaped channel double-structure microneedle device for repairing soft tissue defects

技术领域Technical Field

本发明涉及一种医疗器械,特别是一种软组织缺损修复的异形通道双结构微针装置。The invention relates to a medical device, in particular to a special-shaped channel double-structure microneedle device for repairing soft tissue defects.

背景技术Background Art

微针因其独特的成分和结构,在皮肤创伤、角膜损伤、心肌梗死、子宫内膜损伤、脊髓损伤等多种组织再生中受到广泛关注。微针可以有效穿透坏死组织或生物膜的屏障,提高治疗药物的生物利用度。使用微针递送生物活性分子、细胞修复药物和生长因子可以实现缺损组织的愈合与修复。Microneedles have attracted extensive attention in the regeneration of various tissues, such as skin trauma, corneal injury, myocardial infarction, endometrial injury, and spinal cord injury, due to their unique composition and structure. Microneedles can effectively penetrate the barriers of necrotic tissue or biofilm and improve the bioavailability of therapeutic drugs. The use of microneedles to deliver bioactive molecules, cell repair drugs, and growth factors can achieve the healing and repair of defective tissues.

微针的分层结构源于昆虫触手的分层结构,通过分层微针与皮肤组织的物理互锁,分层微针的粘附能力不受恶劣环境(例如大量失血、伤口面凹凸不平)的影响,因此适用于不同部位的出血区域。The layered structure of the microneedles is derived from the layered structure of insect tentacles. Through the physical interlocking of the layered microneedles with the skin tissue, the adhesion ability of the layered microneedles is not affected by harsh environments (such as massive blood loss and uneven wound surfaces), and is therefore suitable for bleeding areas in different locations.

异形通道在微针中的应用能够极大提高药物递送效率。异形通道可以根据药物递送的需求进行设计,提高药物渗透性和吸收率,改善治疗效果。除此之外,异形通道所形成的空腔能一定程度上给微针减重,贴合皮肤发生相应变形,提升微针装置与受损组织的连接性。微针内部通道的形状和尺寸优化后,也可以减少微针在穿透皮肤时产生的摩擦和刺激,降低患者的疼痛和不适感,提高治疗舒适度。The application of special-shaped channels in microneedles can greatly improve the efficiency of drug delivery. Special-shaped channels can be designed according to the needs of drug delivery, improve drug permeability and absorption rate, and improve treatment effects. In addition, the cavity formed by the special-shaped channel can reduce the weight of the microneedle to a certain extent, deform accordingly to fit the skin, and improve the connectivity between the microneedle device and damaged tissue. After the shape and size of the internal channel of the microneedle are optimized, the friction and irritation caused by the microneedle when penetrating the skin can also be reduced, reducing the patient's pain and discomfort and improving the comfort of treatment.

微针贴片是将注射针减小到纳米级,可以仅通过范德华相互作用制造出的具有极大柔韧性和对不规则、复杂形貌的地貌呈现高粘附力的贴片装置。可实现快速出血控制以及有效闭合伤口,防止伤口部位过多血液渗漏和外部污染。Microneedle patches are made by reducing injection needles to nanoscale. They can be made through van der Waals interactions alone to have great flexibility and high adhesion to irregular and complex topography. They can achieve rapid bleeding control and effective wound closure, preventing excessive blood leakage and external contamination at the wound site.

近年许多重要的研究集中在组织或器官再生问题上,如骨和软骨、皮肤缺损或伤口愈合、外周神经和牙周组织,具有可控制造参数的细胞外基质材料(ECM)材料由于其对生理和病理环境的良好模拟,已成为生物力学、药物筛选、药物递送和疾病模拟等领域研究人员的辅助工具。ECM广泛存在于生物体内,是机体组织细胞进行一切生物学活动的场所和微环境,由机体细胞合成并分泌到细胞外,分布在细胞表面及细胞之间。其主要成分包括胶原蛋白、纤连蛋白、层粘连蛋白、蛋白聚糖、氨基聚糖及生长因子成分等。这些蛋白质及多糖分子在调节细胞反应等方面起着关键作用,能够诱导并促进细胞的迁移、增殖、分化以及血管生成,是机体组织修复的基础。细胞外基质材料可作为组织修复的理想材料之一,具有广泛的应用前景。In recent years, many important studies have focused on tissue or organ regeneration issues, such as bone and cartilage, skin defects or wound healing, peripheral nerves and periodontal tissues. Extracellular matrix materials (ECM) with controllable manufacturing parameters have become auxiliary tools for researchers in the fields of biomechanics, drug screening, drug delivery and disease simulation due to their good simulation of physiological and pathological environments. ECM is widely present in organisms and is the place and microenvironment for all biological activities of tissue cells in the body. It is synthesized by body cells and secreted outside the cells, distributed on the cell surface and between cells. Its main components include collagen, fibronectin, laminin, proteoglycans, aminoglycans and growth factor components. These proteins and polysaccharide molecules play a key role in regulating cell responses, can induce and promote cell migration, proliferation, differentiation and angiogenesis, and are the basis of tissue repair. Extracellular matrix materials can be used as one of the ideal materials for tissue repair and have broad application prospects.

提供软组织细胞生长环境的可注射细胞外基质材料(IECM)包含复杂的组织成分并模拟天然微环境,提供了有吸引力的生物活性,在软骨组织重塑方面表现出巨大的优势,将IECM加入微针装置是软组织缺损修复的一种有前途的方法。基于IECM的微针装置在软骨再生方面具有巨大优势;例如,再生细胞或修复药物可以均匀地封装到微针中,进入人体后能够形成修复组织用于填充不规则的组织缺损,IECM提供的软组织细胞生长的环境有利于药物与软组织的融合,引导软组织的快速修复,表明它们在软骨再生方面的潜在应用价值。Injectable extracellular matrix materials (IECM) that provide a growth environment for soft tissue cells contain complex tissue components and simulate natural microenvironments, providing attractive biological activities and showing great advantages in cartilage tissue remodeling. Adding IECM to microneedle devices is a promising method for repairing soft tissue defects. Microneedle devices based on IECM have great advantages in cartilage regeneration; for example, regenerative cells or repair drugs can be evenly encapsulated into microneedles, and after entering the human body, they can form repair tissues to fill irregular tissue defects. The environment for the growth of soft tissue cells provided by IECM is conducive to the fusion of drugs and soft tissues, guiding the rapid repair of soft tissues, indicating their potential application value in cartilage regeneration.

组织修复或再生是最复杂的生物过程之一,是指将受损组织恢复到具有完整功能的正常状态。虽然小损伤可以通过机体的调节来治愈,但对于不可自愈的病理缺陷或大面积损伤通常需要特殊的再生治疗。近年来,随着组织修复机制的深入探索和生物材料的发展,用于微创递送治疗剂的MN已成为促进组织修复和愈合的新兴技术。Tissue repair or regeneration is one of the most complex biological processes, which refers to the restoration of damaged tissue to a normal state with complete functions. Although small injuries can be healed by the body's regulation, special regenerative treatments are usually required for pathological defects or large-area injuries that cannot heal themselves. In recent years, with the in-depth exploration of tissue repair mechanisms and the development of biomaterials, MNs for minimally invasive delivery of therapeutic agents have become an emerging technology to promote tissue repair and healing.

当前常用的软组织修复方法主要有手术缝合、自体组织移植、异体组织移植等。这些方法在临床上都有一定的应用,但也存在不同程度的缺陷。因此,本发明将微针和修复软组织的可注射性细胞外基质材料相结合,利用IECM的可注射性与生物相容性,将微针与药物送到病变部位、与周围组织自然融合在人体组织外也能稳固在关节处、实现药物递送、封存流出的血液、促进组织细胞的快速生长。这种治疗方法可以避免术后疼痛、创面感染、能力恢复时间长等问题,也为组织修复治疗方面提供更多的选择,提高临床治疗效果。The commonly used soft tissue repair methods currently mainly include surgical suture, autologous tissue transplantation, allogeneic tissue transplantation, etc. These methods have certain applications clinically, but also have defects to varying degrees. Therefore, the present invention combines microneedles with injectable extracellular matrix materials for repairing soft tissues, utilizes the injectability and biocompatibility of IECM, delivers microneedles and drugs to the lesion site, and naturally merges with surrounding tissues outside the human body tissue, and can also be stabilized at the joint, realize drug delivery, seal the blood flowing out, and promote the rapid growth of tissue cells. This treatment method can avoid postoperative pain, wound infection, and the problems of long recovery time, and also provides more options for tissue repair treatment, and improves clinical treatment effect.

发明内容Summary of the invention

有鉴于此,本发明提供一种能够在不规则组织表面实现有效粘附以及穿透皮肤能够快速止血的软组织缺损修复的异形通道双结构微针装置。In view of this, the present invention provides a special-shaped channel double-structure microneedle device that can achieve effective adhesion on irregular tissue surfaces and penetrate the skin to quickly stop bleeding and repair soft tissue defects.

为了实现上述目的,本发明一个方面提供的软组织缺损修复的异形通道双结构微针装置,包括:In order to achieve the above-mentioned object, one aspect of the present invention provides a special-shaped channel double-structure microneedle device for repairing soft tissue defects, comprising:

提供软组织细胞生长环境的可注射细胞外基质材料、异形通道分层微针、单层微针、微针基底矩阵和医疗级别隔离片,软组织缺损修复的异形通道双结构微针装置针头上有多层物质覆盖,从内到外依次包含多巴胺(DA)和抗菌肽(AMP,KRWWKWWRRC)、聚己内酯(PCL,Mw~80000)和聚乙烯醇(PVA,30%w/v),75mg/ml的GDP聚合物与光引发剂I2959(1%w/v)和CaCl2(200mmol/l)混合(GDP@Ca2+)的止血明胶,和脱细胞软骨基质材料(DDC),微针基底矩阵外由医疗级别隔离片包裹。Injectable extracellular matrix materials, shaped channel layered microneedles, single-layer microneedles, microneedle base matrices and medical-grade isolation films are provided to provide a growth environment for soft tissue cells. The needles of the shaped channel double-structure microneedle device for repairing soft tissue defects are covered with multiple layers of materials, including dopamine (DA) and antimicrobial peptide (AMP, KRWWKWWRRC), polycaprolactone (PCL, Mw~80000) and polyvinyl alcohol (PVA, 30% w/v) from the inside to the outside, hemostatic gelatin mixed with 75 mg/ml GDP polymer and photoinitiator I2959 (1% w/v) and CaCl2 (200 mmol/l) (GDP@Ca 2+ ), and decellularized cartilage matrix material (DDC). The microneedle base matrix is wrapped by a medical-grade isolation film.

作为优选,软软组织缺损修复的异形通道双结构微针装置的材料选择具有可注射性、生物相容性和支撑性的可注射细胞基质材料(脱细胞软骨基质材料,DDC)。Preferably, the material of the special-shaped channel double-structure microneedle device for repairing soft tissue defects is an injectable cell matrix material (decellularized cartilage matrix material, DDC) with injectability, biocompatibility and support.

作为优选,基于关节部位组织结构特点,软组织缺损修复的异形通道双结构微针装置基底形成的微针长度不一、角度不同、形状不同、直径不同,内部液体输送通道形状不同。关节软骨处的微针为单层微针,高度范围在350~450μm,与基底的夹角为90°,针体底端直径为150~200μm,针尖直径为5~60μm,针尖夹角为30°,内部通道选用圆柱形,置于微针中部,高度范围100~150μm;关节活动处的异形通道分层微针总高为650~800μm,异形通道分层微针的中心轴线与基底的夹角范围为70°~80°,底部的圆柱结构的直径为200~300μm,上端树状结构的直径在400~700μm,上端椎体针尖直径5~60μm,顶端针尖夹角30°,内部通道选择树杈状,通道高度在600~750μm,树杈通道连接于异形通道分层微针。Preferably, based on the tissue structure characteristics of the joint area, the microneedles formed on the base of the special-shaped channel double-structure microneedle device for repairing soft tissue defects have different lengths, angles, shapes, diameters, and different shapes of internal liquid delivery channels. The microneedles at the articular cartilage are single-layer microneedles with a height range of 350-450μm, an angle of 90° with the base, a diameter of 150-200μm at the bottom of the needle body, a diameter of 5-60μm at the tip, an angle of 30° at the tip, and a cylindrical internal channel placed in the middle of the microneedle with a height range of 100-150μm; the total height of the special-shaped channel layered microneedles at the joint movement is 650-800μm, the angle between the central axis of the special-shaped channel layered microneedle and the base ranges from 70° to 80°, the diameter of the cylindrical structure at the bottom is 200-300μm, the diameter of the upper tree-like structure is 400-700μm, the diameter of the upper vertebral needle tip is 5-60μm, the top needle tip angle is 30°, the internal channel is tree-branch shaped, the channel height is 600-750μm, and the tree-branch channel is connected to the special-shaped channel layered microneedle.

与现有软组织修复方式相比,本发明具有以下优势:Compared with existing soft tissue repair methods, the present invention has the following advantages:

(1)本发明材料新颖,软组织缺损修复的异形通道双结构微针装置采用提供适宜软组织细胞生长的生物环境的脱细胞软骨基质材料(DDC)作为微针装置的生物营养层。可注射性外基质作为一种前景广阔的组织工程仿生生物材料,其中DDC应用于关节部位的缺损修复,能够在组织修复的过程中、消除人体免疫系统的排斥反应,引导缺损组织的分化,进一步提高组织修复的效率。微针包含的的DDC具有良好的生物组织引导性,能够提升止血能力,DDC进入人体后引导结缔组织、皮下组织修复,DDC进入人体环境内不会引起排斥反应,修复过程中DDC分子也能够成为受损的肌肉组织、纤维组织的一部分,加快完成破损关节的修复;(1) The material of the present invention is novel. The special-shaped channel double-structure microneedle device for repairing soft tissue defects adopts a decellularized cartilage matrix material (DDC) that provides a biological environment suitable for the growth of soft tissue cells as the biological nutrient layer of the microneedle device. As an injectable exomatrix with broad prospects as a biomimetic biomaterial for tissue engineering, DDC is applied to the repair of defects in joints. It can eliminate the rejection reaction of the human immune system during the process of tissue repair, guide the differentiation of defective tissue, and further improve the efficiency of tissue repair. The DDC contained in the microneedle has good biological tissue guidance and can enhance the hemostatic ability. After entering the human body, DDC guides the repair of connective tissue and subcutaneous tissue. DDC will not cause rejection reaction when entering the human body environment. During the repair process, DDC molecules can also become part of the damaged muscle tissue and fibrous tissue, thereby accelerating the repair of damaged joints.

(2)本发明结构新颖,将微针技术应用于软组织的缺损修复,特别是制成了一种软组织缺损修复的异形通道双结构微针装置,装置刺入受损组织后,异形通道分层微针的空腔结构在外部挤压力和人体内压强的作用下发生横向变形从而稳固在关节部位附近,稳定后,异形通道分层微针内部的异形通道与单层微针内部的柱形通道开始快速输送药液,实现止血、修复组织缺损;(2) The present invention has a novel structure, and applies microneedle technology to repair soft tissue defects. In particular, a special-shaped channel double-structure microneedle device for repairing soft tissue defects is manufactured. After the device penetrates the damaged tissue, the cavity structure of the special-shaped channel layered microneedle undergoes lateral deformation under the action of external squeezing force and the pressure in the human body, thereby being stabilized near the joint. After stabilization, the special-shaped channel inside the special-shaped channel layered microneedle and the columnar channel inside the single-layer microneedle begin to rapidly transport the drug solution, thereby achieving hemostasis and repairing tissue defects.

(3)本发明具有足够的柔韧性与粘附性,软组织缺损修复的异形通道双结构微针装置中包含的PCL、PVA表现出较高的机械强度与环境适应性。微针装置能够适应具有复杂形貌的基材,在出血潮湿条件下也能紧密粘附在组织上;微针装置的爆破压力能达到6.8±0.55kPa,数值大于血压,满足伤口止血密封的要求。同时在拉伸、压缩和扭曲条件下,微针装置在潮湿环境中表现出超过200%的粘附力,出血状态下稳固于组织关节;(3) The present invention has sufficient flexibility and adhesion, and the PCL and PVA contained in the special-shaped channel dual-structure microneedle device for repairing soft tissue defects show high mechanical strength and environmental adaptability. The microneedle device can adapt to substrates with complex morphology and can adhere tightly to tissues under bleeding and humid conditions; the bursting pressure of the microneedle device can reach 6.8±0.55kPa, which is greater than blood pressure and meets the requirements of wound hemostasis and sealing. At the same time, under the conditions of tension, compression and torsion, the microneedle device shows an adhesion of more than 200% in a humid environment, and is firmly attached to tissue joints under bleeding conditions;

(4)本发明软组织缺损修复的异形通道双结构微针装置释放的Ca2+离子、多巴胺和抗菌肽分子具有良好的止血能力并且能够防止微生物感染。载有Ca2+离子的微针进入关节组织后,Ca2+离子释放到靶细胞促进止血,Ca2+通过与血液中的血小板结合来激活凝血级联反应,在Ca2+浓度为200mmol/l时,凝血时间约为6分钟,缩短凝血时间;(4) The Ca 2+ ions, dopamine and antimicrobial peptide molecules released by the special-shaped channel dual-structure microneedle device for repairing soft tissue defects of the present invention have good hemostatic ability and can prevent microbial infection. After the microneedles loaded with Ca 2+ ions enter the joint tissue, the Ca 2+ ions are released to the target cells to promote hemostasis. Ca 2+ activates the coagulation cascade reaction by binding to platelets in the blood. When the Ca 2+ concentration is 200mmol/l, the coagulation time is about 6 minutes, shortening the coagulation time;

(5)本发明软组织缺损修复的异形通道双结构微针装置所采用的医疗级别隔离片能够保证异形通道微针的存储条件,隔离微生物等污染源的污染,实现随用随取的目的;(5) The medical-grade isolation sheet used in the special-shaped channel dual-structure microneedle device for repairing soft tissue defects of the present invention can ensure the storage conditions of the special-shaped channel microneedles, isolate the contamination of microorganisms and other contamination sources, and achieve the purpose of taking them as needed;

(6)本发明软组织缺损修复的异形通道双结构微针装置所采用的多角度针体可以高度贴合关节软骨,在使用该给药装置时,可以实现破损关节和针体的高度贴合,分层针体会提高与关节的连接性,达到精确给药的目的;(6) The multi-angle needle body used in the special-shaped channel dual-structure microneedle device for repairing soft tissue defects of the present invention can be highly fitted to the articular cartilage. When the drug delivery device is used, a high degree of fit between the damaged joint and the needle body can be achieved. The layered needle body can improve the connectivity with the joint, thereby achieving the purpose of precise drug delivery;

(7)本发明安全有效,适用软组织缺损修复,便于较大范围的推广使用。(7) The present invention is safe and effective, suitable for repairing soft tissue defects, and is easy to promote and use on a larger scale.

应当理解,前面的一般描述和以下详细描述都仅是示例性和说明性的,而不是用于限制本公开。It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the disclosure.

本申请文件提供本公开中描述的技术的各种实现或示例的概述,并不是所公开技术的全部范围或所有特征的全面公开。This application document provides an overview of various implementations or examples of the technology described in the present disclosure, and is not a comprehensive disclosure of the entire scope or all features of the disclosed technology.

附图说明BRIEF DESCRIPTION OF THE DRAWINGS

图1、2为一种软组织缺损修复的异形通道双结构微针装置结构示意图。Figures 1 and 2 are schematic diagrams of the structure of a special-shaped channel double-structure microneedle device for repairing soft tissue defects.

图3、4、5、6为异形通道分层微针内外部结构示意图。图7、8、9为单层微针内外部结构示意图。图10为医疗级别隔离片结构示意图。Figures 3, 4, 5, and 6 are schematic diagrams of the internal and external structures of the shaped channel layered microneedles. Figures 7, 8, and 9 are schematic diagrams of the internal and external structures of the single-layer microneedles. Figure 10 is a schematic diagram of the structure of the medical-grade isolation sheet.

具体实施方式DETAILED DESCRIPTION

为了使得本公开实施例的目的、技术方案和优点更加清楚,下面将结合本公开实施例的附图,对本公开实施例的技术方案进行清楚、完整地描述。In order to make the purpose, technical solution and advantages of the embodiments of the present disclosure more clear, the technical solution of the embodiments of the present disclosure will be clearly and completely described below in conjunction with the drawings of the embodiments of the present disclosure.

如图1、2所示,本发明实施例提供的软组织缺损修复的异形通道双结构微针装置。如图3、4、5、6展示了异形通道分层微针内外部结构;图7、8、9展示了单层微针内外部结构;图10展示了医疗级别隔离片的结构。As shown in Figures 1 and 2, the embodiment of the present invention provides a special-shaped channel dual-structure microneedle device for repairing soft tissue defects. Figures 3, 4, 5, and 6 show the internal and external structures of the special-shaped channel layered microneedles; Figures 7, 8, and 9 show the internal and external structures of the single-layer microneedles; and Figure 10 shows the structure of the medical-grade isolation sheet.

所述软组织缺损修复的异形通道双结构微针装置的异形通道分层微针有两种角度的微针,适用于不同关节处软组织的修复,如踝关节、膝关节,可根据不同的修复部位选择不同角度的异形通道分层微针,适用范围更广。所述微针装置内部的异形通道和柱形通能够加速输送修复药物,异形通道微针的通道会随着刺入皮肤组织的深度发生变形,与人体组织发生物理互锁稳固于受伤部位。异形通道双结构微针装置针尖包含以多巴胺(DA)和抗菌肽(AMP,KRWWKWWRRC)、聚己内酯(PCL)和聚乙烯醇(PVA),75mg/ml的GDP聚合物与光引发剂I2959(1%w/v)和CaCl2(200mmol/l)混合(GDP@Ca2+)的止血明胶,和可注射细胞外基质材料(采用脱细胞软骨基质材料,DDC)。针尖中的聚己内酯和聚乙烯醇使微针呈现较高的机械强度、具备在关节出血时对不平整伤口表面的连续有效粘附以及高的血小板粘附能力。金属离子与抗菌肽的结合能够在组织修复中发挥出色的抗菌作用,避免修复缺损组织过程中微生物的进入和二次感染。DDC对人体无害,进入人体后并不会受免疫系统攻击,并为关节受损组织部位的干细胞和血小板提供适宜的的生长环境,成功密封和愈合伤口,有效控制出血,同时DDC是生物吸收性材料,粘结在破损处并逐渐成为人体健康组织的一部分,共同完成修复缺损的软组织。The shaped channel layered microneedles of the shaped channel double structure microneedle device for repairing soft tissue defects have two angles of microneedles, which are suitable for the repair of soft tissues at different joints, such as ankle joints and knee joints. Different angles of shaped channel layered microneedles can be selected according to different repair sites, and the scope of application is wider. The shaped channel and columnar channel inside the microneedle device can accelerate the delivery of repair drugs. The channel of the shaped channel microneedle will deform with the depth of penetration into the skin tissue, and physically interlock with the human tissue to stabilize the injured part. The needle tip of the shaped channel double structure microneedle device contains dopamine (DA) and antimicrobial peptide (AMP, KRWWKWWRRC), polycaprolactone (PCL) and polyvinyl alcohol (PVA), 75mg/ml GDP polymer mixed with photoinitiator I2959 (1% w/v) and CaCl2 (200mmol/l) (GDP@Ca2+) hemostatic gelatin, and injectable extracellular matrix material (using decellularized cartilage matrix material, DDC). The polycaprolactone and polyvinyl alcohol in the needle tip give the microneedle a high mechanical strength, continuous and effective adhesion to uneven wound surfaces during joint bleeding, and high platelet adhesion. The combination of metal ions and antimicrobial peptides can play an excellent antibacterial role in tissue repair, avoiding the entry of microorganisms and secondary infection during the repair of defective tissues. DDC is harmless to the human body and will not be attacked by the immune system after entering the human body. It provides a suitable growth environment for stem cells and platelets in the damaged tissue of the joint, successfully seals and heals wounds, and effectively controls bleeding. At the same time, DDC is a bioabsorbable material that adheres to the damaged area and gradually becomes part of the healthy tissue of the human body, completing the repair of defective soft tissues.

针对膝关节组织缺损修复,根据膝关节的屈伸角度0~130°,异形通道分层微针的底部托槽采用与微针基底夹角80°,依据度膝关节附近软骨厚度2-3mm,,异形通道分层微针总高度在650~800μm,单层微针总高度在350~450μm。异形通道分层微针面刺入于膝关节的附近组织处、单层微针固定于关节活动部位,异形通道分层微针的异形通道和单层微针的柱形通道所释放的Ca2+离子、多巴胺、抗菌肽分子在快速止血的同时又能够修复缺损的结缔组织与细胞,微针中所包含的PVA、PCL分子让微针保持着优秀的机械强度,在人体关节活动时或出血潮湿条件下也能紧密粘附于缺损处,实现快速控制出血并有效闭合伤口。For the repair of knee joint tissue defects, according to the flexion and extension angle of the knee joint of 0-130°, the bottom bracket of the special-shaped channel layered microneedle adopts an angle of 80° with the microneedle base, and according to the thickness of the cartilage near the knee joint of 2-3mm, the total height of the special-shaped channel layered microneedle is 650-800μm, and the total height of the single-layer microneedle is 350-450μm. The special-shaped channel layered microneedle surface is inserted into the tissue near the knee joint, and the single-layer microneedle is fixed to the joint activity site. The Ca 2+ ions, dopamine, and antimicrobial peptide molecules released by the special-shaped channels of the special-shaped channel layered microneedle and the columnar channels of the single-layer microneedle can repair the defective connective tissue and cells while quickly stopping bleeding. The PVA and PCL molecules contained in the microneedle allow the microneedle to maintain excellent mechanical strength, and can also adhere closely to the defect when the human joint is active or under bleeding and moist conditions, so as to achieve rapid control of bleeding and effective closure of the wound.

针对肘关节组织缺损修复,根据肘关节的屈伸角度0~145°,异形通道分层微针的底部托槽采用与微针基底夹角70°,依据度肘关节附近软骨厚度1-2mm,异形通道分层微针总高度在700~800μm,单层微针总高度在350~400μm。异形通道分层微针刺入于肘关节的附近组织处、单层微针穿透皮肤,空腔结构适应受损组织的沟壑表层进行变形稳固,随后释放的DDC分子以及多巴胺(DA)和抗菌肽(AMP)与Ca2+抑制出血部位微生物的增长,提高血小板造血的能力,提供组织修复的最佳生物环境,引导破损组织的细胞生长、促进细胞分化、快速完成封存血液、达到最佳修复效果。For the repair of elbow joint tissue defects, according to the elbow flexion and extension angle of 0-145°, the bottom bracket of the special-shaped channel layered microneedle adopts an angle of 70° with the microneedle base, and according to the thickness of the cartilage near the elbow joint of 1-2mm, the total height of the special-shaped channel layered microneedle is 700-800μm, and the total height of the single-layer microneedle is 350-400μm. The special-shaped channel layered microneedle is inserted into the tissue near the elbow joint, and the single-layer microneedle penetrates the skin. The cavity structure adapts to the groove surface of the damaged tissue to deform and stabilize. The subsequently released DDC molecules, dopamine (DA) and antimicrobial peptides (AMP) and Ca 2+ inhibit the growth of microorganisms in the bleeding site, improve the ability of platelet hematopoiesis, provide the best biological environment for tissue repair, guide the cell growth of damaged tissue, promote cell differentiation, quickly complete the blood sealing, and achieve the best repair effect.

显然,所描述的实施例是本公开的一部分实施例,而不是全部的实施例。基于所描述的本公开的实施例,本领域普通技术人员在无需创造性劳动的前提下所获得的所有其他实施例,都属于本公开保护的范围。Obviously, the described embodiments are only part of the embodiments of the present disclosure, rather than all of the embodiments. Based on the described embodiments of the present disclosure, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present disclosure.

以上实施例仅为本发明的示例性实施例,不用于限制本发明,本发明的保护范围由权利要求书限定。本领域技术人员可以在本发明的实质和保护范围内,对本发明做出各种修改或等同替换,这种修改或等同替换也应视为落在本发明的保护范围内。The above embodiments are only exemplary embodiments of the present invention and are not intended to limit the present invention. The protection scope of the present invention is defined by the claims. Those skilled in the art may make various modifications or equivalent substitutions to the present invention within the essence and protection scope of the present invention, and such modifications or equivalent substitutions shall also be deemed to fall within the protection scope of the present invention.

Claims (10)

1. The special-shaped channel double-structure microneedle device for repairing soft tissue defects is characterized by comprising a matrix substrate and special-shaped channel microneedles, wherein the special-shaped channel microneedles are arranged on the substrate and comprise special-shaped channel layered microneedles and single-layer microneedles, the single-layer microneedles are of cone structures, and a cylindrical straight channel penetrates through the inside of the single-layer microneedles; the bottom of the special-shaped channel layered microneedle is of a cylindrical structure, the top end of the cylindrical structure is of a singular tree-shaped structure formed by overlapping a plurality of layers of cones and cylinders, and a singular tree-shaped liquid channel communicated with the singular tree-shaped structure is penetrated in the special-shaped channel layered microneedle; covering the surface of the special-shaped channel microneedle with a layer of hemostatic and antibacterial molecules of dopamine and antibacterial peptide; the antibacterial molecules are covered with PCL/PVA molecules; PCL/PVA molecules wrap a layer of Ca 2+ ions; covering the acellular cartilage matrix material DDC molecules outside Ca 2+ ions; the outside of the DDC molecules is wrapped by a medical grade separation sheet; when the special-shaped channel double-structure microneedle device for repairing soft tissue defects is used for a damaged joint, a single-layer microneedle acts on a joint cartilage, a special-shaped channel layered microneedle acts on a joint movement part, a cavity structure of the special-shaped channel layered microneedle is transversely deformed and is stably positioned at the joint movement part under the action of external extrusion force and human body pressure, and meanwhile, special-shaped channels inside the special-shaped channel layered microneedle and cylindrical channels inside the single-layer microneedle start to convey tissue repair factors DDC, ca 2+ ions and dopamine, so that defect joint repair is completed.
2. The special-shaped channel double-structure microneedle device for soft tissue defect repair according to claim 1, wherein the special-shaped channel layered microneedle internally penetrates through a singular tree-shaped delivery channel, and the single-layer microneedle internally penetrates through a cylindrical straight-shaped delivery channel.
3. The shaped channel double-structure microneedle device for soft tissue defect repair according to claim 2, wherein the surface of the needle tip of the shaped channel microneedle is a hemostatic and antibacterial layer containing dopamine and antibacterial peptide.
4. A shaped channel double structure microneedle device for soft tissue defect repair according to claim 3, wherein the hemostatic antibacterial layer is covered with a high strength protective layer comprising polycaprolactone PCL and polyvinyl alcohol PVA.
5. The shaped channel double structure microneedle device for soft tissue defect repair of claim 4, wherein the high strength protective layer is provided with a hemostatic ion layer containing hemostatic Ca 2+.
6. The double-structured micro-needle device with special-shaped channels for repairing soft tissue defects according to claim 5, wherein the hemostatic ion layer is arranged outside the double-structured micro-needle device and comprises a biological nutrition layer of a decellularized cartilage matrix material DDC.
7. The shaped channel double structure microneedle device for soft tissue defect repair of claim 6, wherein the outside of the biological nutrition layer is an isolation layer comprising a medical grade isolation sheet.
8. The special-shaped channel double-structure microneedle device for repairing soft tissue defects according to claim 1, wherein the height range of the single-layer microneedle is 350-450 μm, the included angle between the single-layer microneedle and a substrate is 90 degrees, the diameter of the bottom end of a needle body is 150-200 μm, the diameter of a needle tip is 5-60 μm, the included angle between the needle tip is 30 degrees, the internal channel is cylindrical and is arranged in the middle of the single-layer microneedle, and the height range is 100-150 μm; the total height of the layering microneedle of the special-shaped channel is 650-800 mu m, the included angle range of the central axis of the layering microneedle and the substrate is 70-80 degrees, the diameter of a cylindrical structure at the bottom of the microneedle is 200-300 mu m, the diameter of a conical structure at the upper end is 400-700 mu m, the diameter of the tip of a cone at the upper end is 5-60 mu m, the included angle of the tip is 30 degrees, the internal channel is in a crotch shape, the height of the channel is 600-750 mu m, and the crotch channel is connected with the layering microneedle.
9. The special-shaped channel double-structure microneedle device for soft tissue defect repair according to claim 1, wherein the structure of the cavity inside the special-shaped channel microneedle reduces the weight of the needle, and the cavity formed by the special-shaped channels inside the special-shaped channel layered microneedle is transversely deformed and fixed when contacting with tissues.
10. The profiled channel double-structure microneedle device for soft tissue defect repair according to claim 1, wherein the preparation method of the microneedle comprises the following steps:
s1, drilling holes on the surface of a polydimethylsiloxane plate by adopting a laser micro-machining method to obtain two corresponding microneedle mould pieces, wherein one microneedle mould piece is a special-shaped channel layered microneedle mould piece, and the other microneedle mould piece is a single-layer microneedle mould piece;
s2, dripping an antibacterial peptide solution and a dopamine solution on the surface of the prepared polydimethylsiloxane microneedle mould sheet, placing the microneedle mould sheet in a vacuum oven, vacuumizing at room temperature, and then drying the surface of a needle point in air to obtain a hemostatic antibacterial layer of the special-shaped channel double-structure microneedle device;
S3, preparing a polyvinyl alcohol solution by using deionized water, dripping 1ml of the polyvinyl alcohol solution on the hemostatic antibacterial layer, drying the surface in air, preparing a polycaprolactone solution by using methylene dichloride, dripping the polycaprolactone solution on the dried hemostatic antibacterial layer, drying by nitrogen flow, and treating the polycaprolactone layer by using plasma to obtain a high-strength protective layer of the special-shaped channel double-structure microneedle device;
s4, mixing 75mg/ml of guanosine diphosphate polymer with a photoinitiator I2959 and CaCl 2 to prepare a solution, dripping 1ml of the solution on the dried polycaprolactone layer, drying the solution through nitrogen flow, and then crosslinking the solution for 1 to 8 minutes under ultraviolet irradiation to obtain a hemostatic ion layer of the special-shaped channel double-structure microneedle device;
S5, finally covering the acellular cartilage matrix material on the dried hemostatic ion layer to form a layer of biological nutrition film, so as to obtain a biological nutrition layer of the special-shaped channel double-structure microneedle device, and demolding;
S6, drying the formed microneedle after demolding, punching by using a ultramicropore puncher, and punching by using crotch-shaped and cylindrical punching needles to respectively obtain a special-shaped channel layered microneedle substrate matrix sheet and a single-layer microneedle substrate matrix sheet, thereby obtaining a special-shaped channel double-structure microneedle sheet;
and S7, connecting the prepared special-shaped channel double-structure microneedle sheet with the single-layer microneedle substrate matrix sheet through biological glue and the medical grade separation sheet to obtain the complete special-shaped channel double-structure microneedle device for repairing soft tissue defects.
CN202410953806.6A 2024-07-16 2024-07-16 Special-shaped channel double-structure microneedle device for repairing soft tissue defects Pending CN118903670A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202410953806.6A CN118903670A (en) 2024-07-16 2024-07-16 Special-shaped channel double-structure microneedle device for repairing soft tissue defects

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202410953806.6A CN118903670A (en) 2024-07-16 2024-07-16 Special-shaped channel double-structure microneedle device for repairing soft tissue defects

Publications (1)

Publication Number Publication Date
CN118903670A true CN118903670A (en) 2024-11-08

Family

ID=93311854

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202410953806.6A Pending CN118903670A (en) 2024-07-16 2024-07-16 Special-shaped channel double-structure microneedle device for repairing soft tissue defects

Country Status (1)

Country Link
CN (1) CN118903670A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119971284A (en) * 2025-03-04 2025-05-13 北京化工大学 An integrated hemostatic drug-loaded microneedle patch

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108653814A (en) * 2018-05-22 2018-10-16 北京清源伟业生物组织工程科技有限公司 A kind of preparation method of Acellular cartilaginous matrix material
CN109771815A (en) * 2019-03-25 2019-05-21 南京智谱分子医学技术研究院有限公司 Preparation method of inclined anisotropic microneedle array, microneedle array, microneedle and application
CN111467667A (en) * 2020-04-17 2020-07-31 南京鼓楼医院 A kind of multilayer microneedle array and preparation method thereof
CN113181106A (en) * 2016-01-11 2021-07-30 沃达瑞公司 Microneedle compositions and methods of use thereof
CN115154876A (en) * 2022-05-24 2022-10-11 北京化工大学 A biomimetic porous microneedle transdermal drug delivery system in the shape of wheat ears
US20230310822A1 (en) * 2020-09-07 2023-10-05 Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences Coated microneedle with multilayer structure, method for preparing the same and microneedle patch comprising coated microneedle
WO2023217747A1 (en) * 2022-05-09 2023-11-16 University College Dublin, National University Of Ireland, Dublin Microneedle

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113181106A (en) * 2016-01-11 2021-07-30 沃达瑞公司 Microneedle compositions and methods of use thereof
CN108653814A (en) * 2018-05-22 2018-10-16 北京清源伟业生物组织工程科技有限公司 A kind of preparation method of Acellular cartilaginous matrix material
CN109771815A (en) * 2019-03-25 2019-05-21 南京智谱分子医学技术研究院有限公司 Preparation method of inclined anisotropic microneedle array, microneedle array, microneedle and application
CN111467667A (en) * 2020-04-17 2020-07-31 南京鼓楼医院 A kind of multilayer microneedle array and preparation method thereof
US20230310822A1 (en) * 2020-09-07 2023-10-05 Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences Coated microneedle with multilayer structure, method for preparing the same and microneedle patch comprising coated microneedle
WO2023217747A1 (en) * 2022-05-09 2023-11-16 University College Dublin, National University Of Ireland, Dublin Microneedle
CN115154876A (en) * 2022-05-24 2022-10-11 北京化工大学 A biomimetic porous microneedle transdermal drug delivery system in the shape of wheat ears

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119971284A (en) * 2025-03-04 2025-05-13 北京化工大学 An integrated hemostatic drug-loaded microneedle patch

Similar Documents

Publication Publication Date Title
JP5074182B2 (en) Particles for soft tissue augmentation
Chopra et al. Strategies and therapies for wound healing: a review
Daunton et al. A history of materials and practices for wound management
JP5611979B2 (en) System for providing fluid flow to neural tissue [cross-reference of related applications]
RU2710345C2 (en) Systems and methods for tissue healing
EP1488816B1 (en) Closed cell culture system
CN107158452B (en) Bone wound hemostatic composition and preparation method and application thereof
Radmanesh et al. 3D printed bio polymeric materials as a new perspective for wound dressing and skin tissue engineering applications: a review
MX2010007282A (en) Mucosal tissue dressing and method of use.
TW201141548A (en) Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
CN103394116A (en) Hydrogel dressing capable of promoting wound healing and preparation method thereof
JP2010512865A (en) Wound or tissue dressing containing lactic acid bacteria
CA3138899A1 (en) Tissue derived porous matrices and methods for making and using same
CN118903670A (en) Special-shaped channel double-structure microneedle device for repairing soft tissue defects
CN110623792A (en) A kind of medical dressing and preparation method thereof
Reksodiputro et al. Platelet-rich fibrin enhances wound epithelialization in the skin graft donor site
KR20180046685A (en) Injectable Curcumin/Gellan Gum Hydrogels for Cartilage Regeneration
AU2019223434B2 (en) Multilayer composite material
CN115785480B (en) A baicalein composite hydrogel with fluidity and degradability, and preparation method and application thereof
US20080118551A1 (en) Denatured human albumin biomaterial as dressing for burns and wounds of skin
RU2312658C1 (en) Film-forming aerosol for wound protection in treatment and method for its using
Miller et al. Problems related to the maintenance of chronic percutaneous electronic leads
CN117018283A (en) Multi-layer nano-fiber artificial dura mater using polyaryletherketone as substrate and preparation method thereof
TWI782850B (en) Three-dimensional network aqueous gel and method for producing the same
Parimi Role of scaffolds in wound care and management

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination